Relationship between the level of antibodies to the RA-33 antigen and the course of rheumatoid arthritis
https://doi.org/10.25789/YMJ.2024.88.02
Abstract
The relationship between serum levels antibodies to the RA-33 antigen and the characteristics of the course rheumatoid arthritis (RA) has been studied. The level anti-RA-33 was assessed in a group of RA patients and healthy donors.
The increase in the level anti-RA-33, compared with donors, is statistically significant and was observed in 12.5% RA patients. In patients with an increased level anti-RA-33 (more than 20.5 U/ml), pronounced functional disorders were more often detected. Thus, antibodies to anti-RA33 can potentially provide additional diagnostic value in RA.
About the Authors
B. V. Zavodovsky
ФГБНУ «НИИ КиЭР им. А.Б. Зборовского»
Russian Federation
Russian Federation
Yu. R. Akhverdyan
ФГБНУ «НИИ КиЭР им. А.Б. Зборовского»
Russian Federation
Russian Federation
E. V. Papichev
ФГБНУ «НИИ КиЭР им. А.Б. Зборовского»
Russian Federation
Russian Federation
Yu. V. Polyakova
ФГБНУ «НИИ КиЭР им. А.Б. Зборовского»
Russian Federation
Russian Federation
L. E. Sivordova
ФГБНУ «НИИ КиЭР им. А.Б. Зборовского»
Russian Federation
Russian Federation
References
1. Avdeeva AS, Cherkasova MV, Nasonov EL. Different clinical relevance of anti-citrullinated proteins antibodies in RA patients // Rheumatol ogy Science and Practice. 2022;60(2):181–187. doi: 10.47360/1995-4484-2022-181-187
2. Volkova MV, Kunder AV, Roggenbuck D. Diag nostic value of anti-SA antibodies and antibodies to heterogeneous nuclear ribonucleoprotein K in rheumatoid arthritis. // Siberian Medical Review. 2020; (6):57-63. doi: 10.20333/2500136-2020-6 57-63
3. Dibrov DA. New laboratory biomarkers of rheumatoid arthritis // Rheumatology Sci ence and Practice. 2021; 59(2): 201–207. doi: 10.47360/1995-4484-2021-201-207
4. Mazurov V.I., Gajdukova I.Z. Rheumatoid ar thritis – diagnostic and treatment principles. Me thodical recommendations // Russian Scientific Medical Society of Therapists. 2021. 19 s.
5. Ministry of Health of the Russian Federation. Clinical recommendations «Rheumatoid arthri tis». M., 2021.
6. Nasonov EL, Avdeeva AS, Dibrov DA. Rheu matoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease // Rheumatology Science and Prac tice. 2023; 61(3):276–291. doi: 10.47360/19954484-2023-276-291.
7. Cush JJ. Rheumatoid Arthritis: Early Di agnosis and Treatment // Med Clin North Am. 2021 Mar; 105(2):355-365. doi: 10.1016/j.mcna.2020.10.006.
8. Deane KD, Holers VM. Rheumatoid Arthri tis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift. // Arthritis Rheumatol. 2021 Feb;73(2):181-193. doi: 10.1002/art.41417.
9. Diagnostic performance of anti-RA33 an tibody as a serological marker for rheumatoid arthritis / Syed Mohamed Suhail SM, Nur Atiqah I, Nur Salimi Zakirah ZA, Lailatul Syazwani Z, Batis WW, Md Monoto EM, Abdul Wahab A, Mohd Shahrir MS. // Malays J Pathol. 2019 Dec;41(3):259-265.
10. Diagnostic value of semi-quantitative grading of musculoskeletal ultrasound in wrist and hand lesions of subclinical synovitis in rheu matoid arthritis / Huang Y, Liu KJ, Chen GW, Liu JF, Mo FQ, Xie YH. // Am J Nucl Med Mol Imag ing. 2022 Feb 15;12(1):25-32.
11. Kolarz B, Podgorska D, Podgorski R. Insights of rheumatoid arthritis biomarkers. // Biomarkers. 2021 May;26(3):185-195. doi: 10.1080/1354750X.2020.1794043.
12. Seronegative rheumatoid arthritis: one year in review 2023. / De Stefano L, D'Onofrio B, Gandolfo S, Bozzalla Cassione E, Mauro D, Manzo A, Ciccia F, Bugatti S. // Clin Exp Rheu matol. 2023 Mar;41(3):554-564. doi: 10.55563/clinexprheumatol/go7g26.
Review
For citations:
Zavodovsky B.V., Akhverdyan Yu.R., Papichev E.V., Polyakova Yu.V., Sivordova L.E. Relationship between the level of antibodies to the RA-33 antigen and the course of rheumatoid arthritis. Yakut Medical Journal. 2024;(4):9-12. (In Russ.) https://doi.org/10.25789/YMJ.2024.88.02
Views:
30
Email this article 